These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 10084578)

  • 1. Selective lack of growth hormone (GH) response to the GH-releasing peptide hexarelin in patients with GH-releasing hormone receptor deficiency.
    Maheshwari HG; Rahim A; Shalet SM; Baumann G
    J Clin Endocrinol Metab; 1999 Mar; 84(3):956-9. PubMed ID: 10084578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth hormone-releasing peptide-2 stimulates GH secretion in GH-deficient patients with mutated GH-releasing hormone receptor.
    Gondo RG; Aguiar-Oliveira MH; Hayashida CY; Toledo SP; Abelin N; Levine MA; Bowers CY; Souza AH; Pereira RM; Santos NL; Salvatori R
    J Clin Endocrinol Metab; 2001 Jul; 86(7):3279-83. PubMed ID: 11443201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of GHRP-2 and hexarelin, two synthetic GH-releasing peptides, on GH, prolactin, ACTH and cortisol levels in man. Comparison with the effects of GHRH, TRH and hCRH.
    Arvat E; di Vito L; Maccagno B; Broglio F; Boghen MF; Deghenghi R; Camanni F; Ghigo E
    Peptides; 1997; 18(6):885-91. PubMed ID: 9285939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endocrine activities of ghrelin, a natural growth hormone secretagogue (GHS), in humans: comparison and interactions with hexarelin, a nonnatural peptidyl GHS, and GH-releasing hormone.
    Arvat E; Maccario M; Di Vito L; Broglio F; Benso A; Gottero C; Papotti M; Muccioli G; Dieguez C; Casanueva FF; Deghenghi R; Camanni F; Ghigo E
    J Clin Endocrinol Metab; 2001 Mar; 86(3):1169-74. PubMed ID: 11238504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. d-Lys-GHRP-6 does not modify the endocrine response to acylated ghrelin or hexarelin in humans.
    Benso A; Prodam F; Lucatello B; Gramaglia E; Riganti F; Schneider H; van der Lely AJ; Muccioli G; Ghigo E; Broglio F
    Neuropeptides; 2007 Feb; 41(1):45-9. PubMed ID: 17112585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of the growth hormone releasing peptide hexarelin with somatostatin.
    Massoud AF; Hindmarsh PC; Brook CG
    Clin Endocrinol (Oxf); 1997 Nov; 47(5):537-47. PubMed ID: 9425393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of histaminergic antagonists on the GH-releasing activity of GHRH or hexarelin, a synthetic hexapeptide, in man.
    Arvat E; Maccagno B; Ramunni J; Gianotti L; Di Vito L; Deghenghi R; Camanni F; Ghigo E
    J Endocrinol Invest; 1997 Mar; 20(3):122-7. PubMed ID: 9186817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hexarelin decreases slow-wave sleep and stimulates the secretion of GH, ACTH, cortisol and prolactin during sleep in healthy volunteers.
    Frieboes RM; Antonijevic IA; Held K; Murck H; Pollmächer T; Uhr M; Steiger A
    Psychoneuroendocrinology; 2004 Aug; 29(7):851-60. PubMed ID: 15177700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hexarelin is a stronger GH-releasing peptide than GHRH in normal cycling women but not in anorexia nervosa.
    Giusti M; Foppiani L; Ponzani P; Cuttica CM; Falivene MR; Valenti S
    J Endocrinol Invest; 1997 May; 20(5):257-63. PubMed ID: 9258804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phenotype and genetic analysis of a syndrome caused by an inactivating mutation in the growth hormone-releasing hormone receptor: Dwarfism of Sindh.
    Maheshwari HG; Silverman BL; Dupuis J; Baumann G
    J Clin Endocrinol Metab; 1998 Nov; 83(11):4065-74. PubMed ID: 9814493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tyr-Ala-Hexarelin, a synthetic octapeptide, possesses the same endocrine activities of Hexarelin and GHRP-2 in humans.
    Arvat E; Di Vito L; Lanfranco F; Broglio F; Giordano R; Benso A; Muccioli GP; Deghenghi R; Ghigo E
    J Endocrinol Invest; 1999 Feb; 22(2):91-7. PubMed ID: 10195374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GH and cortisol rebound rise during and following a somatostatin infusion: studies in dogs with the use of a GH-releasing peptide.
    Rigamonti AE; Bonomo SM; Cella SG; Müller EE
    J Endocrinol; 2002 Sep; 174(3):387-94. PubMed ID: 12208658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human fetal pituitary expresses functional growth hormone-releasing peptide receptors.
    Shimon I; Yan X; Melmed S
    J Clin Endocrinol Metab; 1998 Jan; 83(1):174-8. PubMed ID: 9435437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased GH secretion and enhanced ACTH and cortisol release after ghrelin administration in Cushing's disease: comparison with GH-releasing peptide-6 (GHRP-6) and GHRH.
    Correa-Silva SR; Nascif SO; Lengyel AM
    Pituitary; 2006; 9(2):101-7. PubMed ID: 16832586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hexarelin, a novel GHRP-6 analog, stimulates growth hormone (GH) release in a GH-secreting rat cell line (GH1) insensitive to GH-releasing hormone.
    Giustina A; Bonfanti C; Licini M; Ragni G; Stefana B
    Regul Pept; 1997 May; 70(1):49-54. PubMed ID: 9250581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of repeated administration of hexarelin, a growth hormone releasing peptide, and growth hormone releasing hormone on growth hormone responsivity.
    Massoud AF; Hindmarsh PC; Matthews DR; Brook CG
    Clin Endocrinol (Oxf); 1996 May; 44(5):555-62. PubMed ID: 8762732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth hormone-releasing peptides and the cardiovascular system.
    Muccioli G; Broglio F; Valetto MR; Ghè C; Catapano F; Graziani A; Papotti M; Bisi G; Deghenghi R; Ghigo E
    Ann Endocrinol (Paris); 2000 Feb; 61(1):27-31. PubMed ID: 10790589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of hexarelin on growth hormone (GH) secretion in patients with GH deficiency.
    Loche S; Cambiaso P; Merola B; Colao A; Faedda A; Imbimbo BP; Deghenghi R; Lombardi G; Cappa M
    J Clin Endocrinol Metab; 1995 Sep; 80(9):2692-6. PubMed ID: 7673411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulsatile growth hormone secretion persists in genetic growth hormone-releasing hormone resistance.
    Maheshwari HG; Pezzoli SS; Rahim A; Shalet SM; Thorner MO; Baumann G
    Am J Physiol Endocrinol Metab; 2002 Apr; 282(4):E943-51. PubMed ID: 11882517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hexarelin-induced growth hormone, cortisol, and prolactin release: a dose-response study.
    Massoud AF; Hindmarsh PC; Brook CG
    J Clin Endocrinol Metab; 1996 Dec; 81(12):4338-41. PubMed ID: 8954038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.